Depreciation in USD of Akero Therapeutics, Inc. from 2020 to 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Akero Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from 2020 to 2024.
  • Akero Therapeutics, Inc. Depreciation for the quarter ending March 31, 2024 was $1K, a 90.9% decline year-over-year.
  • Akero Therapeutics, Inc. annual Depreciation for 2024 was $18K, a 37.9% decline from 2023.
  • Akero Therapeutics, Inc. annual Depreciation for 2023 was $29K, a 32.6% decline from 2022.
  • Akero Therapeutics, Inc. annual Depreciation for 2022 was $43K, a 4.88% increase from 2021.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)

Akero Therapeutics, Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $1K -$10K -90.9% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-12
Q1 2023 $11K $0 0% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q1 2022 $11K $0 0% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q1 2021 $11K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06

Akero Therapeutics, Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $18K -$11K -37.9% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-28
2023 $29K -$14K -32.6% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-28
2022 $43K +$2K +4.88% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-28
2021 $41K +$24K +141% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-29
2020 $17K Jan 1, 2020 Dec 31, 2020 10-K 2022-02-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.